Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02600845 · ClinicalTrials.gov registry record · NA
ACCU-CHEK Connect Personal Diabetes Management Study (PDM CONNECT)
A NA study, sponsored by Hoffmann-La Roche.
- Completed
- Registry status
- NA
- Development phase
- 122
- Enrollment target
NCT02600845 is a NA study that has completed, run by Hoffmann-La Roche. The registered enrollment target is 122 participants.
The verdict
NCT02600845, a NA study, has completed, sponsored by Hoffmann-La Roche.
- COMPLETED
- Registry status
- NA
- Development phase
- 122 participants
- Enrollment target
Study Summary
This post-market, interventional, prospective, single arm, the United States (US) based multi-center study will assess the change in treatment satisfaction of participants who utilize the ACCU-CHEK Connect Diabetes Management System over a period of 6 months.
Interventions
- DEVICE ACCU-CHEK
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 122 participants |
| Start Date | 2015-12-30 |
| Est. Completion | 2017-02-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02600845
The ClinicalTrials.gov registry entry for NCT02600845 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 122 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hoffmann-La Roche, which has 909 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ACCU-CHEK is the first listed.
NCT02600845 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02600845 about?
NCT02600845 is a clinical study titled "ACCU-CHEK Connect Personal Diabetes Management Study (PDM CONNECT)". This post-market, interventional, prospective, single arm, the United States (US) based multi-center study will assess the change in treatment satisfaction of participants who utilize the ACCU-CHEK Connect Diabetes Management System over a period of 6 months.
What is the current status of trial NCT02600845?
This trial is currently completed. It is a NA study. The enrollment target is 122 participants. The study started on 2015-12-30. Estimated completion is 2017-02-20.
What interventions are being tested in trial NCT02600845?
The interventions under investigation include: ACCU-CHEK (DEVICE).
Who is sponsoring clinical trial NCT02600845?
This trial is sponsored by Hoffmann-La Roche, which has 909 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.